199 related articles for article (PubMed ID: 3110354)
1. Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.
Espevik T; Figari IS; Shalaby MR; Lackides GA; Lewis GD; Shepard HM; Palladino MA
J Exp Med; 1987 Aug; 166(2):571-6. PubMed ID: 3110354
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta 1 primes macrophages for enhanced expression of the nitric oxide synthase gene for nitric oxide-dependent cytotoxicity against Entamoeba histolytica.
Lin JY; Seguin R; Keller K; Chadee K
Immunology; 1995 Jul; 85(3):400-7. PubMed ID: 7558128
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1.
Espevik T; Figari IS; Ranges GE; Palladino MA
J Immunol; 1988 Apr; 140(7):2312-6. PubMed ID: 3280680
[TBL] [Abstract][Full Text] [Related]
4. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
Alleva DG; Burger CJ; Elgert KD
J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
[TBL] [Abstract][Full Text] [Related]
5. Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state.
Yamamoto N; Zou JP; Li XF; Takenaka H; Noda S; Fujii T; Ono S; Kobayashi Y; Mukaida N; Matsushima K
J Immunol; 1995 Mar; 154(5):2281-90. PubMed ID: 7868900
[TBL] [Abstract][Full Text] [Related]
6. Effects of associated cytokines (IL-1, TNF-alpha, IFN-gamma and TGF-beta) on collagen and glycosaminoglycan production by cultured human synovial cells.
Daireaux M; Redini F; Loyau G; Pujol JP
Int J Tissue React; 1990; 12(1):21-31. PubMed ID: 2117000
[TBL] [Abstract][Full Text] [Related]
7. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.
Ding AH; Nathan CF; Stuehr DJ
J Immunol; 1988 Oct; 141(7):2407-12. PubMed ID: 3139757
[TBL] [Abstract][Full Text] [Related]
8. Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma.
Ding A; Nathan CF; Graycar J; Derynck R; Stuehr DJ; Srimal S
J Immunol; 1990 Aug; 145(3):940-4. PubMed ID: 2115549
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist.
Tripp CS; Wolf SF; Unanue ER
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3725-9. PubMed ID: 8097322
[TBL] [Abstract][Full Text] [Related]
10. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
11. Production of transforming growth factor-beta by Mycobacterium avium-infected human macrophages is associated with unresponsiveness to IFN-gamma.
Bermudez LE
J Immunol; 1993 Mar; 150(5):1838-45. PubMed ID: 8436819
[TBL] [Abstract][Full Text] [Related]
12. Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta.
Nedwin GE; Svedersky LP; Bringman TS; Palladino MA; Goeddel DV
J Immunol; 1985 Oct; 135(4):2492-7. PubMed ID: 3928750
[TBL] [Abstract][Full Text] [Related]
13. [Differential growth inhibition of mycobacteria by interferon-gamma-or tumor necrosis factor-alpha-treated murine peritoneal macrophages].
Sato K; Tomioka H; Saito H
Kekkaku; 1996 Nov; 71(11):607-14. PubMed ID: 8958673
[TBL] [Abstract][Full Text] [Related]
14. Effects of growth factors on the antiproliferative activity of tumor necrosis factors.
Sugarman BJ; Lewis GD; Eessalu TE; Aggarwal BB; Shepard HM
Cancer Res; 1987 Feb; 47(3):780-6. PubMed ID: 3802082
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma and transforming growth factor-beta modulate the activation of mitogen-activated protein kinases and tumor necrosis factor-alpha production induced by Fc gamma-receptor stimulation in murine macrophages.
Rose DM; Winston BW; Chan ED; Riches DW; Henson PM
Biochem Biophys Res Commun; 1997 Sep; 238(1):256-60. PubMed ID: 9299489
[TBL] [Abstract][Full Text] [Related]
16. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A
Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154
[TBL] [Abstract][Full Text] [Related]
17. Effects of combinations of transforming growth factor-beta 1 and tumor necrosis factor on induction of differentiation of human myelogenous leukemic cell lines.
Kamijo R; Takeda K; Nagumo M; Konno K
J Immunol; 1990 Feb; 144(4):1311-6. PubMed ID: 2105994
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of epidermal growth factor, transforming growth factor-alpha, and vaccinia virus growth factor in the positive regulation of IFN-gamma production.
Abdullah NA; Torres BA; Basu M; Johnson HM
J Immunol; 1989 Jul; 143(1):113-7. PubMed ID: 2499624
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.
Ranges GE; Figari IS; Espevik T; Palladino MA
J Exp Med; 1987 Oct; 166(4):991-8. PubMed ID: 3498791
[TBL] [Abstract][Full Text] [Related]
20. Cytokine regulation of tumor necrosis factor-alpha and -beta (lymphotoxin)-messenger RNA expression in human peripheral blood mononuclear cells.
Kasid A; Director EP; Stovroff MC; Lotze MT; Rosenberg SA
Cancer Res; 1990 Aug; 50(16):5072-6. PubMed ID: 1696166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]